PWMG
TMO icon

Prestige Wealth Management Group’s Thermo Fisher Scientific TMO Stock Holding History

Prestige Wealth Management Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Sell
928
-420
-31% -$202K 0.08% 112
2026
Q1 		$663K Sell
1,348
-21
-2% -$11.4K 0.13% 84
2025
Q4 		$794K Buy
1,369
+1,249
+1,041% +$706K 0.15% 76
2025
Q3 		$58.3K Sell
120
-15
-11% -$6.98K 0.01% 248
2025
Q2 		$54.8K Sell
135
-1
-0.7% -$418 0.01% 247
2025
Q1 		$67.7K Hold
136
– – 0.01% 228
2024
Q4 		$70.8K Hold
136
– – 0.01% 228
2024
Q3 		$84.2K Buy
136
+75
+123% +$44.4K 0.02% 206
2024
Q2 		$33.8K Buy
61
+6
+11% +$3.44K 0.01% 264
2024
Q1 		$32K Hold
55
– – 0.01% 294
2023
Q4 		$29.2K Sell
55
-18
-25% -$8.71K 0.01% 299
2023
Q3 		$37K Buy
73
+11
+18% +$5.86K 0.01% 269
2023
Q2 		$32.4K Sell
62
-1,124
-95% -$607K 0.01% 306
2023
Q1 		$684K Buy
1,186
+1,116
+1,594% +$629K 0.17% 64
2022
Q4 		$38.6K Sell
70
-976
-93% -$517K 0.01% 279
2022
Q3 		$531K Buy
1,046
+109
+12% +$61K 0.15% 67
2022
Q2 		$510K Buy
937
+6
+0.6% +$3.3K 0.14% 71
2022
Q1 		$550K Buy
931
+871
+1,452% +$500K 0.14% 74
2021
Q4 		$40K Buy
60
+7
+13% +$4.37K 0.01% 284
2021
Q3 		$30K Buy
53
+8
+18% +$4.39K 0.01% 312
2021
Q2 		$23K Buy
45
+2
+5% +$944 0.01% 345
2021
Q1 		$20K Sell
43
-1
-2% -$477 0.01% 364
2020
Q4 		$20K Sell
44
-111
-72% -$52K 0.01% 358
2020
Q3 		$69K Hold
155
– – 0.02% 207
2020
Q2 		$56K Sell
155
-219
-59% -$73.4K 0.02% 211
2020
Q1 		$106K Buy
374
+263
+237% +$82.9K 0.04% 121
2019
Q4 		$36K Sell
111
-7
-6% -$2.12K 0.02% 228
2019
Q3 		$34K Buy
118
+8
+7% +$2.29K 0.02% 226
2019
Q2 		$32K Hold
110
– – 0.02% 225
2019
Q1 		$30K Sell
110
-103
-48% -$25.6K 0.02% 226
2018
Q4 		$48K Buy
+213
New +$50K 0.04% 197

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Prestige Wealth Management Group's TMO Position: Q2 2026 in Review

Prestige Wealth Management Group reduced its Thermo Fisher Scientific (TMO) stake by 31% in Q2 2026, selling an estimated $202K and leaving 928 shares worth $466K. The position accounts for 0.08% of the portfolio, ranked #112.

Prestige Wealth Management Group first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. The position peaked at $794K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Prestige Wealth Management Group held 928 shares of Thermo Fisher Scientific worth $466K as of Q2 2026.
  • Prestige Wealth Management Group sold 420 Thermo Fisher Scientific shares in Q2 2026, an estimated $202K.
  • Thermo Fisher Scientific made up 0.08% of Prestige Wealth Management Group's portfolio in Q2 2026, its #112 holding.
  • Prestige Wealth Management Group first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
  • Prestige Wealth Management Group's Thermo Fisher Scientific position peaked at $794K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.